NELSEN ROBERT 4
4 · Vir Biotechnology, Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
NELSEN ROBERT
Director10% Owner
Transactions
- Award
Common Stock
2024-05-30+8,000→ 584,148 total - Award
Stock Option (Right to Buy)
2024-05-30+16,000→ 16,000 totalExercise: $10.39From: 2025-05-30Exp: 2034-05-29→ Common Stock (16,000 underlying)
Holdings
- 7,290,655(indirect: See footnote)
Common Stock
- 5,626,008(indirect: See footnote)
Common Stock
- 33,893(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
- [F2]The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
- [F3]Shares held by a trust for the benefit of family members of the Reporting Person.